Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
BMC Infectious Diseases|August 28, 2022
Epidemiological and viral characteristics of undiagnosed HIV infections in BotswanaLynnette Bhebhe, Sikhulile Moyo, Simani Gaseitsiwe, et al.
Viruses|May 25, 2024
Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in BotswanaOntlametse T Bareng, Sikhulile Moyo, Mbatshi Mudanga, et al.
Viruses|October 26, 2024
Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIVKabo Baruti, Wonderful T Choga, Patience C Motshosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2025
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo StudyGbolahan Ajibola, Bryan S Nelson, Aischa Niesar, et al.
The Lancet. Infectious Diseases|December 5, 2016
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort studyJohn Gregson, Pontiano Kaleebu, Vincent C Marconi, et al.
AIDS (London, England)|May 16, 2018
Undisclosed antiretroviral drug use in Botswana: implication for national estimatesSikhulile Moyo, Simani Gaseitsiwe, Kathleen M Powis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2024
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trialMarley D Bishop, Violet Korutaro, Ceejay L Boyce, et al.
Plos Medicine|June 22, 2012
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trialShahin Lockman, Michael Hughes, Fred Sawe, et al.
Scientific Reports|October 24, 2023
Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in BotswanaNatasha O Moraka, Wonderful T Choga, Marea N Pema, et al.
Research Square|September 11, 2023
Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in BotswanaNatasha Onalenna Moraka, Wonderful T Choga, Marea N Pema, et al.
Pageof 27